Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119584 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Active
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT03119584 is a Phase 4 study that is active but no longer recruiting, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 23 participants.
The verdict
NCT03119584, a Phase 4 study, is active but no longer recruiting, sponsored by Texas Tech University Health Sciences Center, El Paso.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
Study includes 5 visits, when all basic clinical information, vital signs, symptoms, and side effects are going to be assessed at each appointment. Patients are going to be assigned by the computer, to receive an active or non-active drug for 14 days in a first phase. The order will be change during the second phase. The 2 weeks break without our medication will separate these phases. A very close observation regarding safety of our subjects will be implemented by study personnel and clinical investigators.
Interventions
- DRUG linaclotide or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2027-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03119584
The ClinicalTrials.gov registry entry for NCT03119584 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which linaclotide or placebo is the first listed.
NCT03119584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03119584 about?
NCT03119584 is a clinical study titled "Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation". Study includes 5 visits, when all basic clinical information, vital signs, symptoms, and side effects are going to be assessed at each appointment. Patients are going to be assigned by the computer, to receive an active or non-active drug for 14 days in a first phase. The order will be change durin...
What is the current status of trial NCT03119584?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2015-09-01. Estimated completion is 2027-01.
What interventions are being tested in trial NCT03119584?
The interventions under investigation include: linaclotide or placebo (DRUG).
Who is sponsoring clinical trial NCT03119584?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.